ATB-320

ATB-320
Product Description

[Immune Targeting Dual MOA anti-cancer agent] – Pre-clinical toxicology, TK, and safety pharmacology studies are ongoing and expect to be approved for Phase I IND by US FDA in 1st quarter of 2023

1. Confirmation of the synergistic effect of combination therapy with PD-1 & cytotoxic drugs in pre-clinical study
2. Targeting the undruggable with ASO which is difficult to be modulated by antibodies or small molecules

2. Increase binding affinity (efficacy) and plasma stability (half-life) through chemical modification

3. Secure the efficacy and safety data for pancreatic cancer and bile duct cancer compared to the standard therapy in pre-clinical study

Autotelic Bio

  • KR
  • 2021
    On CPHI since
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator
Specifications
  • Model
    AntiSense Oligonucleotide
  • Supplied from
    Korea, Republic of

Autotelic Bio

  • KR
  • 2021
    On CPHI since
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator

More Products from Autotelic Bio (3)

  • ATB-330

    Product ATB-330

    [ALK5 inhibitor / Small Molecule / Develop for IPF and Fibrosis) – Complete to derivate the lead compound

    1. Confirm the highest ALK5 selectivity with superior efficacy and PK profile through in-vivo tests compared to competitors (small molecule new drugs) 
    ...
  • ATB-101

    Product ATB-101

    [ARB+SGLT-2i Fixed Dose Combination] – In process of Phase 3 clinical trial on approx. 250 patients
    1. The first Fixed Dose Combination treating hypertension and type 2 diabetes by a tablet in the world

    2. Expect the synergistic effect in the treatment of hypertension though mi...
  • ATB-301

    Product ATB-301

    [TGF-β2 Targeting ASO (TASO) + IL-2 Combination therapy] - Phase Ib

    1. Confirm the potential of TGF-β2 as a biomarker in human blood and tumor tissues from the efficacy result of Phase Ib clinical trial on cancer patients 

    2. Confirm the suppression of IL-2’s side effect in combinati...

Autotelic Bio resources (1)